| Prev Close | 16.56 |
| Open | 16.52 |
| Day Low/High | 16.20 / 16.68 |
| 52 Wk Low/High | 9.71 / 16.99 |
| Volume | 187.31K |
| Avg Volume | 298.40K |
| Exchange | NASDAQ |
| Shares Outstanding | 36.79M |
| Market Cap | 604.07M |
| EPS | -1.20 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
AngioDynamics Becomes Oversold (ANGO)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Endo international, AngioDynamics Lead Biotech Movers
Endo International slipped 5% ahead of market's open Friday.
ANGO Crosses Above Average Analyst Target
In recent trading, shares of AngioDynamics Inc have crossed above the average analyst 12-month target price of $17.40, changing hands for $17.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?
In what's shaping up to be a tough year ahead, small-cap companies could bring the 'animal spirits' that the economy and investors need.
5 Stocks Everyone Hates -- but You Should Love
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
AngioDynamics Reaches Analyst Target Price
In recent trading, shares of AngioDynamics Inc have crossed above the average analyst 12-month target price of $16.50, changing hands for $16.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
